avatar
Edward Nirenberg @enirenberg.bsky.social

All voting VRBPAC members have recommended a monovalent JN.1 lineage vaccine for the 2025-2026 formulation; This does not mean that JN.1 itself will be the spike in the vaccine- JN.1 lineage includes many subvariants including LP.8.1 etc. VRBPAC is discussing which one would be best now.

may 22, 2025, 6:51 pm • 18 4

Replies

avatar
Daniella @daniellakrn.bsky.social

Ed- Would you get a booster from another country because I’m not sure we will have them?

may 22, 2025, 6:58 pm • 0 0 • view
avatar
Edward Nirenberg @enirenberg.bsky.social

If it came down to it yeah. I'm hoping we don't get there though

may 22, 2025, 7:02 pm • 1 0 • view
avatar
Daniella @daniellakrn.bsky.social

Just tell me what to get and where :)

may 22, 2025, 7:57 pm • 0 0 • view
avatar
Adithya Ramachandran 🇨🇦 @adithyar.bsky.social

If you don't have them available, that reduces the likelihood of them being available elsewhere too. It's a financial decision for pharma companies and the US was their largest single market before the magas politicized it.

may 23, 2025, 10:10 am • 0 0 • view
avatar
Theo Sonobe @theosonobe.bsky.social

lol recommending a monovalent, JN.1-lineage As opposed to an XBB 👽 The FDA meeting notes even looked like they’d only been slightly modified from last year’s 🫠

may 22, 2025, 7:49 pm • 0 0 • view